Print Page  |  Close Window

VYGR

Voyager Therapeutics Inc
Common Stock

$20.53

+0.32
1.58%
Data as of: 10/16/17  4:00 p.m. ET

Corporate Profile

Voyager Therapeutics is developing life-changing gene therapies for fatal and debilitating diseases of the central nervous system.

Our management team has deep expertise and a track record of building exceptional life science companies.

Learn More